Users Online: 180

Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 

    Article Cited by others


Adverse effects of botulinum neurotoxin A in spasticity management

Joshi Tapan N, Joshi Sonal

Year : 2011| Volume: 1| Issue : 2 | Page no: 126-133

   This article has been cited by
1 DD04107-Derived neuronal exocytosis inhibitor peptides: evidences for synaptotagmin-1 as a putative target
Daniel Butrón,Héctor Zamora-Carreras,Isabel Devesa,Miguel A. Treviño,Olga Abian,Adrián Velázquez-Campoy,M. Ángeles Bonache,Laura Lagartera,Mercedes Martín-Martínez,Sara González-Rodríguez,Ana Baamonde,Asia Fernández-Carvajal,Antonio Ferrer-Montiel,M. Ángeles Jiménez,Rosario González-Muñiz
Bioorganic Chemistry. 2021; : 105231
[Pubmed]  [Google Scholar] [DOI]
2 Central Nervous System Toxicity After Botulinum Neurotoxin Injection
Yashar Ilkhchoui,Ramsis F. Ghaly,N. Nick Knezevic,Kenneth D Candido
Anesthesiology and Pain Medicine. 2013; 3(1): 223
[Pubmed]  [Google Scholar] [DOI]


Read this article